Tag: TCT 2021
“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021
Early data presented ...
TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve
Six-month results fro...
TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system
Early data for the se...
TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens
Patients receiving an...
TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella
The final results of ...
TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up
Left atrial appendage...
TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke
Five-year clinical an...
TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting
One-year outcomes from th...
TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents
Results from SUGAR, a ran...
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation
Six-month outcomes fr...
TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial
Lesion selection for perc...
TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease
Percutaneous coronary...
TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic has announced f...
Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021
Procyrion has announced t...
